SAB Member Prof. Gerding interviewed by Equity Development
News
Friday November 26, 2021
SAB Member Prof. Gerding interviewed by Equity Development
Professor Dale Gerding, a world leader in C. difficile infections and a member of the Destiny Pharma Scientific Advisory Board recently spoke to Equity Development about the significant problem of […]
Wednesday November 24, 2021
Destiny Pharma highlighted in WH Ireland analyst note
Destiny Pharma is pleased to be highlighted in an analyst note from WH Ireland titled, “WHI Sector Comment: Strategic themes in healthcare: an AIM perspective“. A copy of the report […]
Thursday November 4, 2021
SAB Member Prof. Gerding is Keynote at C.diff Conference
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma’s SAB Member Professor Dale Gerding is Keynote Speaker at C. diff. International Conference Brighton, United Kingdom – 4th November 2021 […]